OFM
Omega Fund Management Portfolio holdings
AUM
$154M
1-Year Est. Return
32.78%
1 Year Est. Return
-32.78%
AUM
$154M
AUM Growth
-$15M
(-8.9%)
Holding
13
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBNX
1
Beta Bionics
BBNX
$1.03B
| $28.9M | 18.75% |
1,988,287
|
|
||
|
KMTS
2
Kestra Medical Technologies
KMTS
$1.39B
| $27.3M | 17.67% |
1,645,893
-150,000
|
|
||
|
UPB
3
Upstream Bio Inc
UPB
$1.27B
| $22.4M | 14.48% |
2,036,293
|
|
||
4
Nuvation Bio
NUVB
$1.73B
| $21.5M | 13.94% |
11,042,728
-2,029,612
|
|
||
|
BCAX
5
Bicara Therapeutics
BCAX
$928M
| $20.5M | 13.26% |
2,204,650
|
|
||
6
Replimune Group
REPL
$728M
| $18.3M | 11.88% |
1,975,203
|
|
||
7
Lexeo Therapeutics
LXEO
$708M
| $4.76M | 3.08% |
1,184,636
|
|
||
|
IMA
8
ImageneBio Inc
IMA
$93.4M
| $3.01M | 1.95% |
187,427
|
|
||
9
Sana Biotechnology
SANA
$1.35B
| $2.3M | 1.49% |
843,750
|
|
||
|
ALMS
10
Alumis Inc
ALMS
$501M
| $1.96M | 1.27% |
653,223
|
|
||
11
enGene Holdings
ENGN
$407M
| $1.92M | 1.24% |
526,357
|
|
||
12
Immunic
IMUX
$82.4M
| $1.25M | 0.81% |
1,788,160
|
|
||
|
13
enGene Holdings Warrants
ENGNW
$24.6M
| $273K | 0.18% |
321,502
|
|